Canada
Valeant Canada is a specialty pharmaceutical company and a subsidiary of Valeant Pharmaceuticals International. Valeant Canada manufactures and markets pharmaceuticals products, primarily in the areas of Neurology, Psychiatry, Pain Management and Dermatology. Based in Montreal, Quebec, Valeant Canada employs approximately 150 people.
Valeant Canada's key neurology products are Cesamet®, an oral antiemitic for chemotherapy-induced nausea, M.O.S and M.O.S.-SR®, a Morphine Hydrochloride Opioid Analgesic, and Xyrem®, a central nervous system (CNS) depressant. Additionally, Valeant Canada's key dermatology products are Kinerase®, Dermatix®, Efudex®, and Oxsoralen-Ultra®.
In 2006, The Canadian IMS Health ranked Valeant Canada as the third fastest growing brand manufacturers by total ethical purchases.
Commercial and Manufacturing Facility Address:
4787 Levy Street
Montreal, Quebec H4R 2P9
Canada
+1.514.744.6792
+1.514.744.6272 (fax)